Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis Obliterans
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Allogeneic Hematopoietic Stem Cell Recipients
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Enrollment
- 14
- Locations
- 1
- Primary Endpoint
- Host response in both blood and respiratory tract after PIV infection
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
Bronchiolitis obliterans (BO) is the well-known manifestation of the chronic pulmonary graft-versus-host disease(GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). The pathophysiology of BO is, however, poorly known. The available data strongly support the role of respiratory viruses, in particular paramyxoviruses (parainfluenzae virus (PIV), respiratory syncytial virus, metapneumovirus). It is likely that the alloimmune response triggered by the respiratory virus is inadequate and leads to the peribronchiolar fibrotic process. The objective is to analyze the kinetics of profiles of the blood and respiratory host responses resulting from a high or low parainfluenza respiratory infection, in order to evaluate if the occurrence of a BO is associated with a specific signature We will evaluate the predictive signature of a BO after a parainfluenza virus infection by characterizing the differences between the patients evolving and those not evolving to a BO at 2 months after the infection.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Presence of a respiratory virus infection other than PIV
- •Viral respiratory co-infections
- •Bacterial or fungal respiratory infections
- •Treatment with ribavirin, oseltamivir or any other antiviral with activity against respiratory viruses
- •Patient not affiliated or beneficiary of a social security system
- •Patient deprived of liberty or protected
- •Pregnant or breastfeeding woman
Outcomes
Primary Outcomes
Host response in both blood and respiratory tract after PIV infection
Time Frame: Up to 6 months
Secondary Outcomes
- Evaluate differences in transcriptomic profiles between blood and respiratory tract(Up to 6 months)
- Identify the cellular signaling pathways associated with the development of BO following parainfluenzae virus infection(Up to 6 months)